Kura Oncology Inc. (KURA)

Trade KURA now with
12/20/2017 6:26:59 PM Wedbush Starts Kura Oncology Inc. (KURA) At Outperform With $19 Price Target
12/11/2017 10:03:16 AM Kura Oncology Reports New Findings Supporting Development Of Lead Candidate Tipifarnib
10/16/2017 7:37:50 AM Kura Reports Late-Breaking Presentations For Tipifarnib In HRAS Mutant Squamous Head, Neck Cancer And For KO-539 In AML